Press release
Marburg Virus Disease Clinical Trials 2023: FDA Approvals, Therapies, Treatment Market and Key Companies by DelveInsight | BioCryst Pharmaceuticals, Bavarian Nordic, Flow Pharma, Public Health Vaccines and Others
Marburg Virus Disease Clinical Trials
It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
To know more about the Marburg Virus Pipeline report offerings, click here @ Marburg Virus Disease Pipeline Analysis - https://www.delveinsight.com/report-store/marburg-virus-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some facts of the Marburg virus Pipeline report are:
• Leading Marburg Virus companies such as Bavarian Nordic, BioCryst Pharmaceuticals, Integrated Biotherapeutics, Geovax, Batavia Biosciences, Globavir Biosciences, Collaboration Pharmaceuticals, Emergex Vaccines, ReiThera, Emergent BioSolutions, Mapp Biopharmaceuticals, Biofactura, Alkido Pharma, Flow Pharma, and others are developing potential drug candidates to improve the Marburg Virus Disease treatment scenario.
• Galidesivir (BCX4430) is a broad-spectrum antiviral in advanced development for the virus treatment. BioCryst is developing galidesivir in partnership with U.S. government agencies and other institutions. In September 2013, NIAID contracted with BioCryst to develop galidesivir to treat Marburg Virus Disease and potentially for other filoviruses, including the Ebola virus. The drug is currently in phase 1 of clinical trials for the treatment of Marburg Virus Disease.
• BioCryst is developing galidesivir in partnership with U.S. government agencies and other institutions. In September 2013, the National Institute of Allergy and Infectious Diseases (NIAID) contracted with BioCryst to develop galidesivir to treat Marburg virus disease and potentially for other filoviruses, including the Ebola virus.
• Integrated BioTherapeutics Inc. (IBT), in May 2021, announced the receipt of a contract valued at up to USD 16.3 million from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop IBT-T03H, a monoclonal antibody for the treatment of Marburg virus disease (MVD).
• Mapp Biopharmaceutical, Inc. has been given an advanced research and development contract for USD 16.5 million with options for an additional USD 30.0 million by the Biomedical Advanced Research and Development Authority (BARDA) at the U.S. Department of Health and Human Services (HHS) to advance MBP091 through the completion of Phase 1 clinical trial. MBP091 is a single human monoclonal antibody (mAb) developed as a pan-Marburg virus therapeutic for the treatment of hemorrhagic fevers that are caused by Marburg and the closely related Ravn virus.
Marburg virus Overview:
Marburg virus was first recognized in 1967, when outbreaks of hemorrhagic fever occurred simultaneously in laboratories in Marburg and Frankfurt, Germany and in Belgrade, Yugoslavia (now Serbia). Marburg hemorrhagic fever (Marburg HF) is a rare but severe hemorrhagic fever which affects both humans and non-human primates. Marburg HF is caused by Marburg virus, a genetically unique zoonotic (or, animal-borne) RNA virus of the filovirus family.
Some of the Marburg Virus Disease Companies are:
• BioCryst Pharmaceuticals
• Bavarian Nordic
• Flow Pharma
• Public Health Vaccines
• AlphaVax
• Emergex Vaccines
• ReiThera
• Globavir Biosciences
• Mapp Biopharmaceutical
• And Many Others
Request for free Sample Report to know in detail about the Marburg Virus Disease clinical trials landscape: https://www.delveinsight.com/sample-request/marburg-virus-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
DelveInsight's Marburg Virus Disease report covers around 6+ products under different phases of clinical development like
• Late-stage products (Phase III and
• Mid-stage products (Phase II and
• Early-stage products (Phase I/II and Phase I) along with the details of
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
Some of the Marburg Virus Disease Therapies are:
• MVA-BN filovirus vaccine
• Galidesivir
• And Many Others
Request for free Sample Report to know in detail about Marburg Virus Disease treatment landscape: https://www.delveinsight.com/sample-request/marburg-virus-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Current Marburg Virus Disease Treatment Scenario and Marburg Virus Disease Emerging Therapies:
• How many companies are developing Marburg Virus Disease drugs?
• How many Marburg Virus Disease drugs are developed by each company?
• How many emerging drugs are in mid-stage, and late-stage of development for Marburg Virus Disease?
• What are the key collaborations (Industry-Industry, Industry-Academia), Mergers and acquisitions, licensing activities related to the Marburg Virus Disease therapeutics?
• What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?
• What are the clinical studies going on for Marburg Virus Disease and their status?
• What are the key designations that have been granted to the emerging drugs?
Request for free Sample Report to know more about epidemiology trends: https://www.delveinsight.com/sample-request/marburg-virus-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents:
Introduction
Executive Summary
Marburg Virus Disease: Overview
Marburg Virus Disease Pipeline Therapeutics
• Comparative Analysis
Marburg Virus Disease Therapeutic Assessment
Marburg Virus Disease - DelveInsight's Analytical Perspective
In-depth Commercial Assessment
Mid Stage Products (Phase II)
• Comparative Analysis
MVA-BN filovirus vaccine: Bavarian Nordic
Drug profiles in the detailed report…..
Early Stage Products (Phase I)
• Comparative Analysis
Galidesivir: BioCryst Pharmaceuticals
Drug profiles in the detailed report…..
Inactive Products
Marburg Virus Disease Companies
Marburg Virus Disease Key Products
Marburg Virus Disease Unmet Needs
Marburg Virus Disease Market Drivers
Marburg Virus Disease Market Barriers
Marburg Virus Disease- Future Perspectives and Conclusion
Marburg Virus Disease Analyst Views
Marburg Virus Disease Key Companies
Appendix
Request for Detailed TOC: https://www.delveinsight.com/sample-request/marburg-virus-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Trending Report:
Bronchial Spasm Market - https://www.delveinsight.com/report-store/bronchial-spasm-market
Complicated Intra Abdominal Infections Market - https://www.delveinsight.com/report-store/complicated-intra-abdominal-infections-market
Menorrhalgia Market - https://www.delveinsight.com/report-store/menorrhalgia-market
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Marburg Virus Disease Clinical Trials 2023: FDA Approvals, Therapies, Treatment Market and Key Companies by DelveInsight | BioCryst Pharmaceuticals, Bavarian Nordic, Flow Pharma, Public Health Vaccines and Others here
News-ID: 3005675 • Views: …
More Releases from DelveInsight Business Research
DARZALEX Market Set to Maintain Leadership in Multiple Myeloma Therapy with Stro …
New York, USA - DelveInsight's latest report, "DARZALEX Market Size, Forecast, and Market Insight - 2032," provides a comprehensive analysis of DARZALEX (daratumumab) market performance, competitive landscape, and future growth projections across the seven major markets (7MM): the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. The report offers key product insights, market dynamics, competitor analysis, regulatory milestones, and forecasted sales trends from 2019 to…
BCL-2 Inhibitors Market Analysis 2034: Competitive Landscape, EMA, PDMA, FDA App …
(Albany, USA) DelveInsight's BCL-2 Inhibitor Market Insights Report provides an in-depth analysis of current treatment practices, emerging therapies, and market trends for BCL-2 inhibitors across the 7MM (the US, EU4, the UK, and Japan) from 2020 to 2034. The report highlights that the BCL-2 inhibitors market is poised for significant growth, fueled by the rising incidence of cancer, increased awareness of these targeted therapies, and a growing pipeline of BCL-2…
Ovarian Cancer Market Insights Highlight Expanding Outlook Till 2034, DelveInsig …
DelveInsight's "Ovarian Cancer Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Ovarian Cancer, historical and forecasted epidemiology as well as the Ovarian Cancer market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Ovarian Cancer market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Ovarian Cancer Market Forecast
https://www.delveinsight.com/sample-request/ovarian-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Knee Osteoarthritis Pipeline 2025: FDA Updates, Therapy Innovations, and Clinica …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Knee Osteoarthritis pipeline constitutes 50+ key companies continuously working towards developing 60+ Knee Osteoarthritis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Knee Osteoarthritis Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Knee Osteoarthritis Market.
The Knee…
More Releases for Marburg
Wallpaper Market Is Booming So Rapidly: Graham & Brown, Marburg, York Contract
HTF Market Intelligence recently released a survey document on Wallpaper market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision-makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, and emerging trends along with essential drivers, challenges, opportunities, and restraints in the Wallpaper…
3D Wallpaper Market Demand & Competitive Analysis by 2026| A.S. Création, Lilyc …
Market Research Report Store offers a latest published report on 3D Wallpaper Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
This intelligence 3D Wallpaper Market report by Market Research Report Store includes investigations based on the current scenarios, historical records, and future predictions. An accurate data of various aspects such as type, size, application, and end user have been scrutinized…
Wallpaper Market Is Booming Worldwide | Marburg, Brewster Home Fashions, York Wa …
HTF MI recently introduced Global Wallpaper Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Asheu, A.S. Création Tapeten, Marburg, Brewster Home Fashions, York Wallpapers, Osborne&little, Zambaiti…
Ebola and Marburg Infections Market Key Futuristic Trends And Competitive Landsc …
Ebola and Marburg Infections Market: Overview
Ebola and Marburg infection is a type of hemorrhagic fever that affects multiple organs of the body and leads to severe illness. These two viruses are native to Africa where intermittent outbreaks of these infections have occurred for decades. Ebola and Marburg viruses live in animal hosts and humans get affected when they come in contact with that infected animal. After this initial transmission…
Ebola and Marburg Infections Market Size, Share, Growth, Trends, Forecast 2024
Ebola and Marburg infection is a type of hemorrhagic fever that affects multiple organs of the body and leads to severe illness. These two viruses are native to Africa where intermittent outbreaks of these infections have occurred for decades. Ebola and Marburg viruses live in animal hosts and humans get affected when they come in contact with that infected animal. After this initial transmission the viruses can spread from person…
Ebola and Marburg Infections Market Present Scenario and Growth Prospects 2016-2 …
Ebola and Marburg Infections Market: Overview
Ebola and Marburg infection is a type of hemorrhagic fever that affects multiple organs of the body and leads to severe illness. These two viruses are native to Africa where intermittent outbreaks of these infections have occurred for decades. Ebola and Marburg viruses live in animal hosts and humans get affected when they come in contact with that infected animal. After this initial transmission the…
